Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Declines By 79.7%

Sysmex Co. (OTCMKTS:SSMXY) saw a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 4,000 shares, a decline of 79.7% from the January 31st total of 19,700 shares. Based on an average daily volume of 113,800 shares, the days-to-cover ratio is currently 0.0 days.

Sysmex Price Performance

Shares of OTCMKTS:SSMXY opened at $18.09 on Friday. The company’s fifty day moving average is $18.49 and its two-hundred day moving average is $19.12. The company has a quick ratio of 2.42, a current ratio of 3.19 and a debt-to-equity ratio of 0.11. Sysmex has a 12-month low of $14.38 and a 12-month high of $28.58. The company has a market cap of $11.39 billion, a P/E ratio of 35.74 and a beta of 0.90.

Sysmex (OTCMKTS:SSMXY) last announced its earnings results on Wednesday, February 12th. The company reported $0.17 earnings per share (EPS) for the quarter. Equities analysts expect that Sysmex will post 0.57 earnings per share for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.